Skip to content

Spectra Optia R Apheresis System

by Caridianbct, Inc..

510(k) K103090

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

4 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 10 Oct 2026. What this means

Regulatory status

as of registry sync 10 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK103090 Date19 Nov 2010ClearedStatusActive

Recalls

4 recalls · FDA

    • Terminated Z-1683-2012 FDA Not yet classified initiated 4 May 2012

    Defective product may result in decreased efficacy.

    • Terminated Z-1504-2012 FDA Unclassified (pre-2012) initiated 26 Oct 2011

    Potential for air entry into the fluid pathway of the COBE Spectra due to a leak at the return luer connection to an elevated bloodwarmer when directions for use are not followed.

    • Terminated Z-0191-2012 FDA Unclassified (pre-2012) initiated 21 Sep 2011

    Possible higher than expected platelet loss following therapeutic plasma exchange or plasmapheresis.

    • Terminated Z-2674-2011 FDA Unclassified (pre-2012) initiated 9 Dec 2010

    An additional air detection system is being added to all existing systems to detect air in the system's return line.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LKN
Device Class
U
Advisory Committee
Unknown
FDA Decision
SESE Substantially Equivalent

Other devices from Caridianbct, Inc..